Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ: BNTX )

119.83 -2.95 (-2.40%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 654,601
Open 119.91
Bid (Size) 117.50 (1)
Ask (Size) 124.00 (1)
Prev. Close 122.78
Today's Range 117.92 - 122.25
52wk Range 76.53 - 131.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.
RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines in favor of his nomination. 
Via Investor's Business Daily

Performance

YTD
+3.93%
+3.93%
1 Month
+6.27%
+6.27%
3 Month
+17.63%
+17.63%
6 Month
+33.25%
+33.25%
1 Year
+30.72%
+30.72%

More News

Read More
Pfizer Edges Higher As Covid Sales Decline, But Still Beat Expectations
Via Investor's Business Daily
Exposures COVID-19
BioNTech Completes Acquisition of Biotheus
From BioNTech SE
Via GlobeNewswire
Peering Into BioNTech's Recent Short Interest
Via Benzinga
Why BioNTech (BNTX) Shares Are Volatile Today
Via Benzinga
Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots
Via Investor's Business Daily
Exposures COVID-19
3 Dirt-Cheap Stocks to Buy in a Market That's Priced for Perfection
Via The Motley Fool
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Via Benzinga
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Via Investor's Business Daily
BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
From BioNTech SE
Via GlobeNewswire
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
Via Benzinga
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Via Benzinga
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Via Investor's Business Daily
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Via Benzinga
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike
Via Investor's Business Daily
Exposures COVID-19
5 Predictions for the Stock Market in 2025 -- and Which Stocks Will Soar the Most If They're Right
Via The Motley Fool
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Via Investor's Business Daily
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Via The Motley Fool
2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
2 No-Brainer Stocks to Buy Before the End of 2024
Via The Motley Fool
Why Is BioNTech Stock Trading Higher On Friday?
Via Benzinga
5 Top Stocks to Buy in December
Via The Motley Fool
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS